Cadence Wealth Management’s CVS Health CVS Stock Holding History

Cadence Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Sell	3,579 -20	-0.6%	-$1.78K	0.17%	48
2026 Q1	$258K	Hold	3,599	–	–	0.11%	53
2025 Q4	$286K	Sell	3,599 -1,000	-22%	-$78.8K	0.14%	50
2025 Q3	$347K	Hold	4,599	–	–	0.18%	47
2025 Q2	$317K	Hold	4,599	–	–	0.21%	44
2025 Q1	$312K	Hold	4,599	–	–	0.23%	37
2024 Q4	$206K	Hold	4,599	–	–	0.14%	45
2024 Q3	$289K	Hold	4,599	–	–	0.24%	33
2024 Q2	$272K	Hold	4,599	–	–	0.19%	39
2024 Q1	$367K	Hold	4,599	–	–	0.38%	28
2023 Q4	$363K	Hold	4,599	–	–	0.29%	28
2023 Q3	$321K	Hold	4,599	–	–	0.27%	29
2023 Q2	$318K	Hold	4,599	–	–	0.31%	24
2023 Q1	$342K	Hold	4,599	–	–	0.35%	19
2022 Q4	$429K	Hold	4,599	–	–	0.37%	14
2022 Q3	$439K	Hold	4,599	–	–	0.41%	17
2022 Q2	$426K	Hold	4,599	–	–	0.44%	16
2022 Q1	$465K	Hold	4,599	–	–	0.36%	18
2021 Q4	$474K	Hold	4,599	–	–	0.52%	16
2021 Q3	$390K	Hold	4,599	–	–	0.44%	20
2021 Q2	$384K	Hold	4,599	–	–	0.32%	25
2021 Q1	$346K	Buy	+4,599	New	+$335K	0.31%	23

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cadence Wealth Management's CVS Position: Q2 2026 in Review

Cadence Wealth Management reduced its CVS Health (CVS) stake by 0.56% in Q2 2026, selling an estimated $1.78K and leaving 3,579 shares worth $370K. The position accounts for 0.17% of the portfolio, ranked #48.

Cadence Wealth Management first reported a position in CVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $474K in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Cadence Wealth Management held 3,579 shares of CVS Health worth $370K as of Q2 2026.
Cadence Wealth Management sold 20 CVS Health shares in Q2 2026, an estimated $1.78K.
CVS Health made up 0.17% of Cadence Wealth Management's portfolio in Q2 2026, its #48 holding.
Cadence Wealth Management first reported a position in CVS Health in Q1 2021 and has held it in 22 quarters since.
Cadence Wealth Management's CVS Health position peaked at $474K in Q4 2021.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cadence Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.